BDSX: Roth Initiates Buy
Roth Capital initiates coverage on Biodesix with a Buy rating and a price target of $32
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Roth Capital initiates coverage on Biodesix with a Buy rating and a price target of $32
Benchmark initiates MPLT and TNXP with a strong buy rating